Cambridge, United Kingdom

Matthew Edward Smith

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 5.8

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Matthew Edward Smith - Pioneering Innovations in Genomic Research

Introduction:

Matthew Edward Smith, a visionary inventor based in Cambridge, GB, has made significant contributions to the field of genomic research. With a portfolio of 5 patents under his name, Smith's work focuses on developing cutting-edge computational methods for detecting and targeting genomic rearrangements.

Latest Patents:

1. Computational method for detecting fusion events: Smith's patent introduces a novel method for detecting gene fusion events by utilizing a set of primers to target DNA molecules of interest. This innovative approach includes bioinformatic analysis to determine the presence of gene fusions, with applications in the diagnosis and treatment of diseases like lung cancer.

2. Method for the analysis of minimal residual disease: Another groundbreaking patent by Smith, this method involves obtaining and analyzing sequence variations in a patient's tumor to detect minimal residual disease. Through targeted multiplex amplification and sequencing of cell-free DNA, this approach provides a precise assessment of disease status.

Career Highlights:

Smith is a key member of the renowned company Inivata Ltd., where he leads cutting-edge research initiatives in genomic medicine. His expertise in developing innovative technologies for precision medicine has garnered recognition within the scientific community.

Collaborations:

Smith collaborates closely with esteemed colleagues such as Samuel Woodhouse and Tim Forshew, who share his passion for revolutionizing genomic diagnostics. Together, they form a dynamic team driving advancements in personalized healthcare solutions.

Conclusion:

Matthew Edward Smith's inventive spirit and dedication to advancing genomic research have positioned him as a trailblazer in the field of precision medicine. His pioneering patents and collaborative efforts underscore his commitment to developing transformative solutions for improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…